人工智能在原发性肝癌外科治疗中的应用现状与展望.
刘红枝， 刘景丰 - Journal of Clinical Hepatology/Linchuang …, 2022 - search.ebscohost.com
刘红枝1 ,刘景丰 Page 1 人工智能在原发性肝癌外科治疗中的应用现状与展望 刘红枝1 ,刘景丰
1,2 1 福建医科大学孟超肝胆医院东南肝胆健康大数据研究所,福州350025; 2 福建省肿瘤医院 …
1,2 1 福建医科大学孟超肝胆医院东南肝胆健康大数据研究所,福州350025; 2 福建省肿瘤医院 …
[HTML][HTML] Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study
C Liu, Z Li, Z Zhang, J Li, C Xu, Y Jia, C Zhang… - BMC …, 2024 - Springer
Purpose Hepatocellular carcinoma (HCC) has a poor prognosis, and alpha-fetoprotein
(AFP) is widely used to evaluate HCC. However, the proportion of AFP-negative individuals …
(AFP) is widely used to evaluate HCC. However, the proportion of AFP-negative individuals …
Prognostic analysis and risk assessment based on RNA editing in hepatocellular carcinoma
X Shi, X Bu, X Zhou, N Shen, Y Chang, W Yu… - Journal of Applied …, 2024 - Springer
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, and
prognosis assessment is crucial for guiding treatment decisions. In this study, we aimed to …
prognosis assessment is crucial for guiding treatment decisions. In this study, we aimed to …
Impact of portal‐phase signal intensity of dynamic gadoxetic acid‐enhanced magnetic resonance imaging in hepatocellular carcinoma
T Tomino, S Itoh, D Okamoto, S Yoshiya… - Journal of Hepato …, 2023 - Wiley Online Library
Purpose To evaluate the prognostic impact of dynamic gadolinium ethoxybenzyl
diethylenetriaminepentaacetic acid (Gd‐EOB‐DTPA)‐enhanced magnetic resonance …
diethylenetriaminepentaacetic acid (Gd‐EOB‐DTPA)‐enhanced magnetic resonance …
Application status and prospect of artificial intelligence in surgical treatment of primary liver cancer
LIU Hongzhi, LIU Jingfeng - 临床肝胆病杂志, 2022 - lcgdbzz.org
Primary liver cancer is one of the most common and fatal malignant tumors, and surgical
treatment is the most important radical treatment method, but there is still a high …
treatment is the most important radical treatment method, but there is still a high …
[HTML][HTML] 甲胎蛋白阴性肝细胞癌患者的预后分析
卢英， 雍景超， 吴志奇 - 南京医科大学学报(自然科学版), 2023 - jnmu.njmu.edu.cn
目的: 分析探讨影响甲胎蛋白(alpha fetoprotein, AFP) 阴性(AFP< 20 ng/mL) 肝细胞癌(
hepatocellular carcinoma, HCC) 患者术后生存的风险因素. 方法: 共纳入479 …
hepatocellular carcinoma, HCC) 患者术后生存的风险因素. 方法: 共纳入479 …
Inflammation-Related Marker NrLR Predicts Prognosis in AFP-Negative HCC Patients After Curative Resection
Q Wu, J Zeng, J Zeng - Journal of Hepatocellular Carcinoma, 2023 - Taylor & Francis
Background The role of inflammation-related markers in alpha-fetoprotein (AFP) negative
hepatocellular carcinoma (HCC) is not well known. This study aimed to investigate the …
hepatocellular carcinoma (HCC) is not well known. This study aimed to investigate the …
A Prediction of Hepatocellular Carcinoma-Associated Cachexia: The Value of a Nomogram Based on Magnetic Resonance Imaging and Serum Characterisitcs
X Li, B Liu, Y Zhao, Y Jiang, H Mao, X Peng - 2023 - researchsquare.com
Materials and Methods A retrospective two-center study recruited the pretreatment clinical
and MRI data of 489 HCC patients undergoing contrast-enhanced abdominal MRI. The data …
and MRI data of 489 HCC patients undergoing contrast-enhanced abdominal MRI. The data …
[PDF][PDF] PREDICTIVE VALUE OF MHC CLASS-I CHAIN-RELATED GENE A (MICA) POLYMORPHISM FOR HEPATOCELLULAR CARCINOMA SUSCEPTIBILITY
PREDICTIVE VALUE OF MHC CLASS-I CHAIN- RELATED GENE A (MICA) POLYMORPHISM
FOR HEPATOCELLULAR CARCINOMA SUSCEPTIBILITY Page 1 ISSN: 03875547 Volume …
FOR HEPATOCELLULAR CARCINOMA SUSCEPTIBILITY Page 1 ISSN: 03875547 Volume …
[PDF][PDF] ПРОВЕДЕННЯ ДИФЕРЕНЦІЙНОЇ ДІАГНОСТИКИ ВОГНИЩЕВИХ УРАЖЕНЬ ПЕЧІНКИ ЗА ДОПОМОГОЮ РАДІОНУКЛІДНИХ МЕТОДІВ «IN VIVO» ТА «IN …
ОВ Миронова, ГО Романенко, АГ Мазур… - scholar.archive.org
Резюме Мета. Провести порівняльний аналіз радіонуклідних методів «in vivo» та «in
vitro» для диференційної діагностики вогнищевих уражень печінки, а саме при …
vitro» для диференційної діагностики вогнищевих уражень печінки, а саме при …